EI

Elizabeth Iorns

CEO at Science Exchange

San Francisco Bay Area

Invests in

  • Min Investment:

    $5,000.00
  • Max Investment:

    $25,000.00
  • Target Investment:

    $15,000.00

Work Experience

  • Co-founder, President & CEO; Board Director

    2011

    Science Exchange is the world's leading marketplace for outsourced research and development, providing efficient access to a network of over 2,500 qualified and pre-contracted contract research organizations (CROs) and manufacturers (CMOs), academic labs, and government facilities. Supported by top venture capital firms including Maverick Capital, Union Square Ventures, Norwest Venture Partners and Y Combinator, Science Exchange has raised more than $60M in venture capital funding.

  • Scientific Founder & Advisor

    2020

    Transcripta Bio (formerly Rarebase) https://www.transcriptabio.com/

2014 - 2020

  • Part-time partner

    2014 - 2020

    Helped to establish the "YC bio" program for early stage life science companies.

2014 - 2020

  • Angel Investor

    2014 - 2020

    Angel investor in science, health and education companies including Asher Biotherapeutics, Avro Therapeutics, Hepatx, Enzyme, Curebase, Notable Labs, NURX, BIOS Health, Torch, Quero Education, Unima, Validere, Vetcove.

2008 - 2011

  • Assistant Professor

    2010 - 2011

  • Postdoctoral Associate

    2008 - 2010

  • Scientific Officer, Breakthrough Breast Cancer Research Center

    2003 - 2004